Strobeck Mark's Form 4 filing
Rockwell Medical, Inc.RMTI · filed Jul 2, 2025
- Accession no.
- 0001628280-25-034068
- Filed
- Jul 2, 2025
- Trade date
- Jul 1, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $5.68K. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001628280-25-034186 (Jul 3, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Strobeck MarkCIK 0001599219 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Common Stock | SSaleDisposed | −6,926 | $0.82 | −$5,679.32 | 337,752 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.